Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer

Genetically determined polymorphisms of N-acetylation and oxidative capacity have been studied using dapsone and metoprolol in 51 Japanese patients with spontaneous bladder cancer and 203 healthy control subjects. The results for N-acetylation pharmacogenetics were against the initial expectation th...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical pharmacology 1989-11, Vol.37 (6), p.581-587
Main Authors: HORAI, Y, FUJITA, K, ISHIZAKI, T
Format: Article
Language:English
Subjects:
Acetylation
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Chi-Square Distribution
Dapsone - analogs & derivatives
Dapsone - blood
Dapsone - metabolism
Disease Susceptibility
Female
General pharmacology
Humans
Japan
Male
Medical sciences
Metoprolol - analogs & derivatives
Metoprolol - blood
Metoprolol - metabolism
Middle Aged
Oxidation-Reduction
Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions
Pharmacology. Drug treatments
Phenotype
Urinary Bladder Neoplasms - epidemiology
Urinary Bladder Neoplasms - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Genetically determined polymorphisms of N-acetylation and oxidative capacity have been studied using dapsone and metoprolol in 51 Japanese patients with spontaneous bladder cancer and 203 healthy control subjects. The results for N-acetylation pharmacogenetics were against the initial expectation that there would be a preponderance of slow acetylators in the cancer group, as 3 such patients (5.9%) were found as compared to 13 (6.4%) in the healthy group. There was no poor metabolizer (PM) of metoprolol in the cancer group, whereas in the healthy group one (0.5%) was a PM. There were no significant differences between the groups in the frequency of slow acetylator and poor oxidiser phenotypes, or in the frequency distribution profiles of acetylation (monoacetyldapsone/dapsone) and oxidative metabolic ratio (log metoprolol/alpha-hydroxymetoprolol). The results indicate that neither N-acetylation nor the debrisoquine/sparteine-type oxidative phenotype and/or capacity represent a genetic predisposition to spontaneous bladder carcinogenesis in Japanese patients. In the normal Japanese population there is a great predominance of rapid acetylators and extensive oxidisers.
ISSN:0031-6970
1432-1041
DOI:10.1007/BF00562549